Publications by authors named "D Botsen"

Claim this Profile
H
Hepatic metastases management: A comparative review of surgical resection, thermal ablation, and stereotactic body radiation therapy.
Paolo Torielli, Jeremy McGale, Matthew J Liao, Rami Rhaiem, Olivier Bouche, Damien Botsen

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a better understanding of patient expectations: ONCOPREMs-1 study-a qualitative study.
Loubna Diouri, Fiona Ecarnot, Sophie Berjot, Alexandre Popiolek, Olivier Bouché, Damien Botsen

Aging Clin Exp Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial.
Aziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, Karine Le Malicot, Simon Pernot, Damien Botsen

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer (EXOSCOL01): A Pilot Case-Controlled Study Focusing on MMP14 Potential.
Mickaël Barhoum, Sylvie Brassart-Pasco, Aurélie Dupont-Deshorgue, Aurore Thierry, Lukshe Kanagaratnam, Damien Botsen

J Clin Lab Anal· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.
E Samalin, L Evesque, A Turpin, C De La Fouchardiere, F Khemissa-Akouz, D Botsen

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis